Second death linked to potential antibody treatment for Alzheimer’s disease
Woman’s brain haemorrhage while receiving Eisai’s widely heralded lecanemab heightens concerns overs its safety
Second death linked to potential antibody treatment for Alzheimer’s disease | Science | AAAS
Bionaut Labs secures $43M for its tiny, drug-carrying robots
Bionaut Labs secures $43M for its tiny, drug-carrying robots (fiercebiotech.com)
MIT researchers reveal DNA "Paste" tech behind latest gene editing startup
MIT researchers reveal DNA – Endpoints News (endpts.com)
Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's
AstraZeneca reveals its cell therapy ambitions with deal for startup
AstraZeneca reveals its cell therapy ambitions with deal for startup | BioPharma Dive
Natural and targeted circuit reorganization after spinal cord injury
Natural and targeted circuit reorganization after spinal cord injury | Nature Neuroscience
After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback
Out of prison, ‘CRISPR babies’ scientist attempts comeback (statnews.com)
Jim Wilson biotech iECURE gets fresh $65M to push paediatric liver disease gene therapy into the clinic
Biomarker of Early-Stage Alzheimer’s Disease Discovered in Urine
Biomarker of Early-Stage Alzheimer's Disease Discovered in Urine | Inside Precision Medicine
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
Detailed data for the companies’ medicine lecanemab help to validate an announcement from two months ago that a key clinical trial had succeeded.
What to make of Eisai and Biogen’s latest Alzheimer’s drug data | BioPharma Dive
Elon Musk says Neuralink’s brain-machine interface could enter human studies next year
Musk: Neuralink brain-machine interface nears human studies (statnews.com)
FDA approves Rebyota, Ferring's poop-based drug to fight C. diff infection
The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells
Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease